• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[进行性系统性硬化症。131例患者的临床谱及预后参数]

[Progressive systemic scleroderma. Clinical spectrum and prognostic parameters in 131 patients].

作者信息

Luderschmidt C, Kaulertz I, König G, Leisner B

出版信息

Dtsch Med Wochenschr. 1984 Sep 14;109(37):1389-97. doi: 10.1055/s-2008-1069383.

DOI:10.1055/s-2008-1069383
PMID:6479031
Abstract

The course of progressive systemic scleroderma was analysed from data collected on 131 patients. Classification was according to the extent of cutaneous involvement, type I (28%): sclerosis as far as the wrist-joint; type II (65%): sclerosis beyond the wrist-joint; type III (7%): sclerosis beginning to affect the trunk. In addition, they were subdivided into those with or without signs of systemic inflammation. The sex ratio was 3.5 females to 1 male. In half of the patients the disease manifested itself between the age of 30 and 50 years, with a clear peak about the 40th year. Serological evidence of inflammatory and immunological phenomena was present in nearly 50%, predominantly in those with type II or III. Oesophageal involvement was present in 84%, of the lung in 56% of all patients. ECG and echocardiographic changes were demonstrated in 34% of patients, while liver, intestines and kidneys were only rarely affected. The degree of organ involvement increased from type I to type III. Signs of systemic inflammation were predominantly associated with a clinically severe course.

摘要

根据收集到的131例患者的数据,对进行性系统性硬化症的病程进行了分析。根据皮肤受累程度进行分类,I型(28%):硬化累及至腕关节;II型(65%):硬化超出腕关节;III型(7%):硬化开始累及躯干。此外,将患者细分为有或无全身炎症体征的两类。男女比例为1:3.5。半数患者在30至50岁之间发病,在40岁左右有一个明显的发病高峰。近50%的患者存在炎症和免疫现象的血清学证据,主要见于II型或III型患者。84%的患者有食管受累,56%的患者有肺部受累。34%的患者有心电图和超声心动图改变,而肝脏、肠道和肾脏受累较少。器官受累程度从I型到III型逐渐增加。全身炎症体征主要与临床严重病程相关。

相似文献

1
[Progressive systemic scleroderma. Clinical spectrum and prognostic parameters in 131 patients].[进行性系统性硬化症。131例患者的临床谱及预后参数]
Dtsch Med Wochenschr. 1984 Sep 14;109(37):1389-97. doi: 10.1055/s-2008-1069383.
2
[Heart involvement in systemic sclerosis: analysis of four cases].[系统性硬化症的心脏受累:4例分析]
Ann Acad Med Stetin. 2012;58(1):33-9; discussion 39.
3
[Cardiac involvement in progressive systemic sclerosis (PSS)].[进行性系统性硬化症(PSS)中的心脏受累]
Boll Soc Ital Cardiol. 1981;26(12):2097-9.
4
[Renal involvement in scleroderma].[硬皮病中的肾脏受累]
Rev Prat. 2002 Nov 1;52(17):1910-4.
5
[Clinical aspects of progressive systemic scleroderma (PSS). Multicenter studies of 194 patients].[进行性系统性硬化症(PSS)的临床方面。194例患者的多中心研究]
Hautarzt. 1986 Jun;37(6):320-4.
6
[Heart involvement in systemic sclerosis].[系统性硬化症中的心脏受累]
Pol Merkur Lekarski. 2016 Sep 29;41(243):156-159.
7
[Cardiac involvement in progressive systemic sclerosis].
Arq Bras Cardiol. 1977 Aug;30(4):281-5.
8
Renal involvement in scleroderma.硬皮病中的肾脏受累情况。
J Assoc Physicians India. 1990 Oct;38(10):768-70.
9
Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis.无硬皮病的系统性硬化症:硬皮病肾危象中的一种不寻常表现。
J Rheumatol. 1995 Mar;22(3):557-60.
10
Scleroderma renal crisis.硬皮病肾危象
Semin Arthritis Rheum. 2015 Jun;44(6):687-94. doi: 10.1016/j.semarthrit.2014.12.001. Epub 2014 Dec 11.

引用本文的文献

1
[An integrated method of pain measurement based on Tursky's pain perception profile, for use in patients with progressive systemic sclerosis.].[一种基于Tursky疼痛感知概况的疼痛测量综合方法,用于进行性系统性硬化症患者。]
Schmerz. 1989 Mar;3(1):28-33. doi: 10.1007/BF02527469.
2
Long-term manometry of tubular esophagus in progressive systemic sclerosis.进行性系统性硬化症患者管状食管的长期测压
Clin Investig. 1994 May;72(5):343-9. doi: 10.1007/BF00252825.
3
Studies on endothelial cell cytotoxic activity in sera of patients with progressive systemic sclerosis, Raynaud syndrome, rheumatoid arthritis, and systemic lupus erythematosus.
对进行性系统性硬化症、雷诺综合征、类风湿性关节炎和系统性红斑狼疮患者血清中内皮细胞细胞毒性活性的研究。
Rheumatol Int. 1985;5(6):259-63. doi: 10.1007/BF00541353.